Back to results
CompletedPhase 1

4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes

NCT00558571

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

1245.4.49003 Boehringer Ingelheim Investigational Site

Berlin, Germany

+2 additional locations

View on ClinicalTrials.gov
4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes — TrialFind